Valuation: OraSure Technologies, Inc.

Market Cap 24Cr 21Cr 20Cr 18Cr 34Cr 2.31TCr 34Cr 236.34Cr 91Cr 1.17TCr 90Cr 88Cr 3.75TCr P/E 2026 *
-5.29x
P/E 2027 * -4.31x
Enterprise Value 24Cr 21Cr 20Cr 18Cr 34Cr 2.31TCr 34Cr 236.34Cr 91Cr 1.17TCr 90Cr 88Cr 3.75TCr EV / Sales 2026 *
1.97x
EV / Sales 2027 * 1.81x
Free-Float
93.64%
Yield 2026 *
-
Yield 2027 * -
1 day+0.29%
1 week+8.05%
Current month-2.79%
1 month-8.40%
3 months-21.92%
6 months+17.11%
Current year+44.21%
1 week 3.22
Extreme 3.22
3.54
1 month 3.14
Extreme 3.145
3.93
Current year 2.33
Extreme 2.33
4.58
1 year 2.08
Extreme 2.08
4.58
3 years 2.08
Extreme 2.08
8.45
5 years 2.08
Extreme 2.08
13.57
10 years 2.08
Extreme 2.08
23.01
Manager TitleAgeSince
Chief Executive Officer 52 04/06/2022
Director of Finance/CFO 54 08/08/2022
Chief Tech/Sci/R&D Officer - 01/12/2024
Director TitleAgeSince
Director/Board Member 59 01/06/2020
Director/Board Member 66 08/11/2021
Director/Board Member 52 04/06/2022
Date Insider Type Main position Quantity % Market Cap. Importance
06/09/26 Tax

Chairman

-5,116 0.0074%
03/06/26 Free

Director

46,106 0.0670%
03/06/26 Free

Director

46,106 0.0670%
Change 5-day change 1-year change 3-year change Capi.($)
+0.29%+8.05%+6.08%-36.89% 24Cr
-0.13%-1.09%-23.81%+0.48% 18TCr
+0.18%+1.26%-1.91%+13.45% 12TCr
-2.85%-3.60%+7.03%+73.54% 6.08TCr
-0.26%+2.81%-3.30%-31.23% 4.95TCr
-0.49%-0.68%+6.93%+40.01% 4.83TCr
+0.68%+4.05%+15.03%-8.74% 3.3TCr
-2.64%-0.83% - - 2.89TCr
+1.27%+6.49%+42.85%-7.00% 2.55TCr
+1.13%+5.26%+10.51%-22.76% 2.18TCr
Average -0.29%+1.98%+6.60%+2.32% 5.64TCr
Weighted average by Cap. -0.37%+0.22%-3.79%+10.41%

Financials

2026 *2027 *
Net sales 12Cr 11Cr 10Cr 9.15Cr 17Cr 1.17TCr 17Cr 119.89Cr 46Cr 594.32Cr 46Cr 45Cr 1.9TCr 13Cr 12Cr 11Cr 9.98Cr 19Cr 1.28TCr 19Cr 130.79Cr 51Cr 648.33Cr 50Cr 49Cr 2.08TCr
Net income -4.62Cr -4.02Cr -3.81Cr -3.46Cr -6.46Cr -442.44Cr -6.5Cr -45Cr -18Cr -224.85Cr -17Cr -17Cr -719.81Cr -5.77Cr -5.02Cr -4.75Cr -4.32Cr -8.07Cr -552.16Cr -8.11Cr -57Cr -22Cr -280.61Cr -22Cr -21Cr -898.31Cr
Net Debt - -
Logo OraSure Technologies, Inc.
OraSure Technologies, Inc. transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its products and services include OraQuick ADVANCE Rapid HIV 1/2 Antibody Test, OraQuick HIV Self-Test, Diagnostics Direct Syphilis Health Check, OraQuick Ebola Rapid Antigen Test, InteliSwab COVID-19 Rapid Test Pro, and SickleSCAN Test, among others. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers.
Employees
500
Date Price Change Volume
17/26/17 $3.490 +0.29% 3,55,530
16/26/16 $3.480 +0.58% 4,15,208
15/26/15 $3.460 +2.67% 14,78,007
14/26/14 $3.370 +3.69% 7,65,965
11/26/11 $3.250 +0.62% 4,67,283
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3.490USD
Average target price
4.000USD
Spread / Average Target
+14.61%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. OSUR Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!